• Search for shares
  • Search content
  • Search author
  • Search topic
Popular:ST is long live. LeTV Internet Café Luo Niushan
Financial commentary
Published on 2018-07-26 09:24:44 Share it web version
                        Long-lived organisms fell for the eighth consecutive day. Several fund companies lowered their valuation to 3.96 yuan.
Source: Eastern Fortune Network

K map 002680_2

Long-lived organisms fell for the eighth consecutive day, and several fund companies lowered their valuations to 3.96 yuan. As of press time, ST Changsheng fell 5.02%, reported 11.16 yuan, and sealed more than 760,000 hands.

Huaxia Fund announced on July 26 that since July 25, the company's funds have been valued at ST Changsheng (002680) at 3.96 yuan. Previously, the Oriental Fund Management Co., Ltd. also issued an announcement. After consultation with the fund custodian, the price of the “Changsheng Bio” stock held by its securities investment fund will be adjusted from July 23, according to its 2017 earnings per share. The net asset value of 3.96 yuan is valued.

  The problem vaccine case has made new progress: the State Council investigation team rushed to Jilin on July 23 to carry out investigations into the case of Changchun Changsheng illegal production of rabies vaccine, and held the first plenary meeting of the investigation team on July 24.

The meeting was chaired by Bi Jingquan, head of the investigation team of the State Council. The meeting called for work on seven aspects:

First, thoroughly investigate the violations of laws and regulations of enterprises involved in the case, comprehensively ascertain the facts of violations of laws and regulations and the flow of vaccines involved in the case, and do a good job in investigation and evidence collection;

Second, severely punish illegal and criminal acts in accordance with the law, seriously investigate and deal with enterprises involved in the case, and severely punish those involved in the case, such as those directly responsible;

The third is to investigate the duty of public officials to perform their duties and find serious accountability for dereliction of duty and dereliction of duty;

The fourth is to carry out scientific risk assessment and research to propose classification and treatment relief measures;

The fifth is to properly handle the follow-up work of the enterprises involved in the case;

Sixth, it is necessary to respond to social concerns, timely announce the progress of investigations, and popularize scientific knowledge of vaccine safety;

The seventh is to study the work measures for reform and improvement of the vaccine management system, and establish and improve a long-term mechanism to ensure the quality and safety of vaccines.

It is worth noting that Changsheng Biotech announced on the evening of the 24th that the company's products have all been discontinued for thorough rectification, and the time for resumption of production is still uncertain. In addition, the company's stock was changed by ST, abbreviated from "longevity" to "ST longevity", suspended on the 25th for one day, and resumed on the 26th.

Regarding the impact of the "vaccine incident" on the company, Gao Junfang's son, Changsheng Biological Vice Chairman Zhang Yihao said in an interview with the media that the company as a whole is in a state of suspension of production. "(The serious consequences for the company) is gone, then what? The delisting is delisted."

  Longevity: Stocks are resold by ST, 26th

On July 24, the Public Security Bureau of Changchun New District issued a notice stating that 15 suspects, including Gao Junfang, chairman of Changchun Changsheng Biotechnology Co., Ltd., were suspected of criminal offences and were subject to criminal detention compulsory measures by the Changchun New District Public Security Bureau.

Subsequently, Changsheng Biology announced that the stock will be suspended from trading on July 25 (Wednesday) and will resume trading on July 26 (Thursday). In addition, the company's stock was implemented on July 26, and other risk warnings were implemented. The short term was changed from “Changsheng Biology” to “ST Changsheng”. The company's stock code is still “002680”, and the company's stock trading day is limited to 5%. .

The announcement mentioned that in recent days, Jilin Food and Drug Administration has recovered the GMP certificate for Changchun Changsheng Rabies Vaccine Drugs. At present, Changchun Changsheng stops the production and sales of rabies vaccine. All products of the subsidiary have been suspended from the batch. At present, in addition to the baibai broken combination vaccine, freeze-dried human rabies vaccine products were ordered to suspend production, the company decided to take a comprehensive and independent production of other products of the company, the above production workshops self-examination and self-correction during the production stoppage, comprehensive and thorough Rectification. The current time for resumption of production is uncertain. The company's production and operation activities have been seriously affected and it is expected that it will not return to normal within three months. According to the provisions of 13.3.1 of the Shenzhen Stock Exchange Listing Rules, the company's stock will implement other risk warnings from the date of resumption of trading.

In addition, Changsheng said that the current time for resumption of production is still uncertain. The event will have a significant negative impact on the company's performance in the second half of 2018. At the same time, due to this violation, it is expected that there will be certain obstacles to the future company's vaccine sales, and will have a significant impact on future business performance. determine.

  Northward funds thunder, 7 days floating loss nearly 100 million

Since the problem vaccine was exposed, the longevity organism has eaten seven consecutive word-limits, a decline of more than 50%, and the market value evaporated by 12.5 billion yuan.

It is worth noting that Changsheng Biotechnology, as a Shenzhen-Hong Kong-based standard, is favored by many northbound funds. In particular, the pharmaceutical stock market since March this year, many North Bank funds began to look for A shares in the pharmaceutical sector.

Since March of this year, the capital of the North has begun to flood into the longevity organism. On March 13, the amount of long-lived creatures held by the North Bank officially exceeded 1 million shares. At the end of June, the number of shares held by the North Bank was close to 9 million shares.

The data showed that before the problem vaccine was exposed, the North Capital held 7,604,300 long-lived creatures. However, it is strange that, on the occasion of the 7 consecutive words of the long-lived creatures, the capital of the North is still a net purchase every day, and the total purchase of 202,000 shares on the 7th.

  If calculated at the closing price on July 13, the capital of Changshang has a market capitalization of 187 million yuan. However, after the 7-word limit, the capital on the north has a floating loss of nearly 100 million yuan.


  [Event Progress]

July 26th:Wuhan bio-made "fish of the net"? Involved in many cases of bribery, 400,000 unqualified vaccines went to the mystery

July 25th:The investigation team of the State Council went to Jilin to carry out investigation and handling of cases

July 24th:The chairman of the longevity creature, daughter-in-law, extravagant life exposure "a huge amount of fines" can not buy her 10 bags!

July 24th:State Food and Drug Administration: conducting a full process and full chain inspection of all Changchun Changsheng vaccines

July 24th:The long-lived creature will be changed to "ST Changsheng" from July 26th. The chairman and other 15 people were detained.

July 24th:Industrial Securities: Gao Junfang's son, Zhang Yihao, pledges 167 million shares of living creatures to track developments in real time

July 24th:Changsheng Biology: The chairman and some senior executives are unable to perform their duties normally. Production and operation are seriously affected.

July 24th:Longevity organisms fell for the seventh consecutive day. The Oriental Fund cut its stock price to 3.96 yuan, equivalent to 10 down limit.

July 24th:Jilin Provincial Commission for Discipline Inspection Commission initiated the investigation of corruption in Changchun Changsheng Biological Vaccine Case

July 23rd:Xi Jinping made important instructions on Jilin Changchun Longevity Biological Vaccine Case

July 23rd:Shenzhen Stock Exchange imposes restrictions on the shares held by Changsheng Bio-related shareholders

July 23rd:Public security organ investigates the suspected illegal crimes of rabies vaccine produced by long-lived organisms

July 23rd:Long-lived creatures received notice of investigation by the Securities and Futures Commission

July 23rd:"Problem Vaccine" Event Continues Fermentation Contax Bio is caught in a paradox

July 23rd:Changchun Changsheng sales agent was involved in 12 bribery cases: the four provinces involved in Henan, Guangdong and Guangdong, who are collecting money

July 23rd:Changchun Changsheng was involved in more than a dozen bribery cases: each 72 yuan rabies vaccine rebate 20 yuan

July 23rd:Is the fund manager of the first performance this year a domestic vaccine platform a rational or an interest?

July 22nd:Li Keqiang gave instructions on the vaccine incident: he must give a clear explanation to the people of the country.

July 22nd:The State Food and Drug Administration has filed an investigation! Longevity: I feel very guilty and embarrassed

July 22nd:The five major official media criticized the longevity problem vaccine: Can you apologize? Have a check!

July 22nd:Changsheng Biological Sales Director: Shandong Province has introduced a plan for the replacement of white and white

July 21st:The king of vaccines is the road to fraud: the boss of the longevity creature has grown to 5.5 billion in ten years.

July 20th:Longevity: It is expected that the rabies vaccine incident will reduce the annual income of 720 million in 2018

July 19th:Changsheng Biology: Changchun Changsheng, a wholly-owned subsidiary, received an administrative penalty decision and was fined 3.44 million yuan.

July 16th:Long-lived biological rabies vaccine production record fraud, the vaccine has not yet flowed to the market

July 15th:The State Food and Drug Administration retracted the GMP certificate for longevity biological drugs and ordered the company to stop rabies vaccine production.

  [Illustrated event]

  Graphic Gao Junfang, Du Weimin, Han Gangjun three "vaccine giants" family history

Published on 2018-07-26 09:25:15
                            it is good!
Published on 2018-07-26 09:25:19
                            The stockholders are miserable
Published on 2018-07-26 09:25:24
                            At least 20 down limits
Published on 2018-07-26 09:25:26
                            Is there a valuation for such a company? Who are you cheating?
Published on 2018-07-26 09:25:26
                            it is good! ! Continue to limit
Published on 2018-07-26 09:25:37
                            Required delisting
Published on 2018-07-26 09:25:41
                            Oh, the top value is one yuan.
Posted on 2018-07-26 09:25:50
                            Still have to continue to limit, you are too wicked
Published on 2018-07-26 09:25:55
                            More than 3 yuan is still too high
Published on 2018-07-26 09:25:57
                            Delisting
Published on 2018-07-26 09:26:02
                            Falling 0 delisting
Posted on 2018-07-26 09:26:08
                            Less, fall another month
Published on 2018-07-26 09:26:14
                            Is there a valuation?
Published on 2018-07-26 09:26:26
                            This is directly delisted, don’t report it,
Published on 2018-07-26 09:26:41
                            Must fall to the market, know Sanlu?
Published on 2018-07-26 09:26:42
                            Dry well, almost like this
Published on 2018-07-26 09:26:45
                            The drug batch number is not given to him. In this industry, it is delisted and worthless.
Published on 2018-07-26 09:27:16
                            This company also has a valuation fund company brain into the water
Published on 2018-07-26 09:27:36
                            it is good
Published on 2018-07-26 09:27:36
                            Some people buy it. . .
Published on 2018-07-26 09:27:41
                            Thumbs up
Posted on 2018-07-26 09:28:05
                            I disappeared from my eyes earlier.
Posted on 2018-07-26 09:28:05
                            It’s too slow, this stock can be T+0
Published on 2018-07-26 09:28:09
                            The down limit is useless! Can only let the bullets fly to solve? Is it a down limit?
Published on 2018-07-26 09:28:19
                            How should the shareholders solve?
Published on 2018-07-26 09:28:21
                            One worthless!
Published on 2018-07-26 09:28:37
                            There are still people who are buying stocks and don’t understand!
Posted on 2018-07-26 09:29:08
                            Is this not normal? Delisting!
Published on 2018-07-26 09:29:28
                            Ok, it has been falling down!
Published on 2018-07-26 09:29:29
                            Some people buy
Comment on this topic
The post is gone! How to do?
Author: You will not be publishedlog in |5 seconds registration Author:, welcome to leave a messagedrop out |Post a new topic
                Tip: All information, comments, etc. published by users in the community represent only personal opinions, and have nothing to do with the position of this website, and do not constitute any investment advice for you. Users should make their own decisions on securities investment and bear the corresponding risks based on their own independent judgment."Review of Self-discipline Management Commitment"
Source: Eastern Fortune Network

K map 002680_2

Long-lived organisms fell for the eighth consecutive day, and several fund companies lowered their valuations to 3.96 yuan. As of press time, ST Changsheng fell 5.02%, reported 11.16 yuan, and sealed more than 760,000 hands.

Huaxia Fund announced on July 26 that since July 25, the company's funds have been valued at ST Changsheng (002680) at 3.96 yuan. Previously, the Oriental Fund Management Co., Ltd. also issued an announcement. After consultation with the fund custodian, the price of the “Changsheng Bio” stock held by its securities investment fund will be adjusted from July 23, according to its 2017 earnings per share. The net asset value of 3.96 yuan is valued.

  The problem vaccine case has made new progress: the State Council investigation team rushed to Jilin on July 23 to carry out investigations into the case of Changchun Changsheng illegal production of rabies vaccine, and held the first plenary meeting of the investigation team on July 24.

The meeting was chaired by Bi Jingquan, head of the investigation team of the State Council. The meeting called for work on seven aspects:

First, thoroughly investigate the violations of laws and regulations of enterprises involved in the case, comprehensively ascertain the facts of violations of laws and regulations and the flow of vaccines involved in the case, and do a good job in investigation and evidence collection;

Second, severely punish illegal and criminal acts in accordance with the law, seriously investigate and deal with enterprises involved in the case, and severely punish those involved in the case, such as those directly responsible;

The third is to investigate the duty of public officials to perform their duties and find serious accountability for dereliction of duty and dereliction of duty;

The fourth is to carry out scientific risk assessment and research to propose classification and treatment relief measures;

The fifth is to properly handle the follow-up work of the enterprises involved in the case;

Sixth, it is necessary to respond to social concerns, timely announce the progress of investigations, and popularize scientific knowledge of vaccine safety;

The seventh is to study the work measures for reform and improvement of the vaccine management system, and establish and improve a long-term mechanism to ensure the quality and safety of vaccines.

It is worth noting that Changsheng Biotech announced on the evening of the 24th that the company's products have all been discontinued for thorough rectification, and the time for resumption of production is still uncertain. In addition, the company's stock was changed by ST, abbreviated from "longevity" to "ST longevity", suspended on the 25th for one day, and resumed on the 26th.

Regarding the impact of the "vaccine incident" on the company, Gao Junfang's son, Changsheng Biological Vice Chairman Zhang Yihao said in an interview with the media that the company as a whole is in a state of suspension of production. "(The serious consequences for the company) is gone, then what? The delisting is delisted."

  Longevity: Stocks are resold by ST, 26th

On July 24, the Public Security Bureau of Changchun New District issued a notice stating that 15 suspects, including Gao Junfang, chairman of Changchun Changsheng Biotechnology Co., Ltd., were suspected of criminal offences and were subject to criminal detention compulsory measures by the Changchun New District Public Security Bureau.

Subsequently, Changsheng Biology announced that the stock will be suspended from trading on July 25 (Wednesday) and will resume trading on July 26 (Thursday). In addition, the company's stock was implemented on July 26, and other risk warnings were implemented. The short term was changed from “Changsheng Biology” to “ST Changsheng”. The company's stock code is still “002680”, and the company's stock trading day is limited to 5%. .

The announcement mentioned that in recent days, Jilin Food and Drug Administration has recovered the GMP certificate for Changchun Changsheng Rabies Vaccine Drugs. At present, Changchun Changsheng stops the production and sales of rabies vaccine. All products of the subsidiary have been suspended from the batch. At present, in addition to the baibai broken combination vaccine, freeze-dried human rabies vaccine products were ordered to suspend production, the company decided to take a comprehensive and independent production of other products of the company, the above production workshops self-examination and self-correction during the production stoppage, comprehensive and thorough Rectification. The current time for resumption of production is uncertain. The company's production and operation activities have been seriously affected and it is expected that it will not return to normal within three months. According to the provisions of 13.3.1 of the Shenzhen Stock Exchange Listing Rules, the company's stock will implement other risk warnings from the date of resumption of trading.

In addition, Changsheng said that the current time for resumption of production is still uncertain. The event will have a significant negative impact on the company's performance in the second half of 2018. At the same time, due to this violation, it is expected that there will be certain obstacles to the future company's vaccine sales, and will have a significant impact on future business performance. determine.

  Northward funds thunder, 7 days floating loss nearly 100 million

Since the problem vaccine was exposed, the longevity organism has eaten seven consecutive word-limits, a decline of more than 50%, and the market value evaporated by 12.5 billion yuan.

It is worth noting that Changsheng Biotechnology, as a Shenzhen-Hong Kong-based standard, is favored by many northbound funds. In particular, the pharmaceutical stock market since March this year, many North Bank funds began to look for A shares in the pharmaceutical sector.

Since March of this year, the capital of the North has begun to flood into the longevity organism. On March 13, the amount of long-lived creatures held by the North Bank officially exceeded 1 million shares. At the end of June, the number of shares held by the North Bank was close to 9 million shares.

The data showed that before the problem vaccine was exposed, the North Capital held 7,604,300 long-lived creatures. However, it is strange that, on the occasion of the 7 consecutive words of the long-lived creatures, the capital of the North is still a net purchase every day, and the total purchase of 202,000 shares on the 7th.

  If calculated at the closing price on July 13, the capital of Changshang has a market capitalization of 187 million yuan. However, after the 7-word limit, the capital on the north has a floating loss of nearly 100 million yuan.


  [Event Progress]

July 26th:Wuhan bio-made "fish of the net"? Involved in many cases of bribery, 400,000 unqualified vaccines went to the mystery

July 25th:The investigation team of the State Council went to Jilin to carry out investigation and handling of cases

July 24th:The chairman of the longevity creature, daughter-in-law, extravagant life exposure "a huge amount of fines" can not buy her 10 bags!

July 24th:State Food and Drug Administration: conducting a full process and full chain inspection of all Changchun Changsheng vaccines

July 24th:The long-lived creature will be changed to "ST Changsheng" from July 26th. The chairman and other 15 people were detained.

July 24th:Industrial Securities: Gao Junfang's son, Zhang Yihao, pledges 167 million shares of living creatures to track developments in real time

July 24th:Changsheng Biology: The chairman and some senior executives are unable to perform their duties normally. Production and operation are seriously affected.

July 24th:Longevity organisms fell for the seventh consecutive day. The Oriental Fund cut its stock price to 3.96 yuan, equivalent to 10 down limit.

July 24th:Jilin Provincial Commission for Discipline Inspection Commission initiated the investigation of corruption in Changchun Changsheng Biological Vaccine Case

July 23rd:Xi Jinping made important instructions on Jilin Changchun Longevity Biological Vaccine Case

July 23rd:Shenzhen Stock Exchange imposes restrictions on the shares held by Changsheng Bio-related shareholders

July 23rd:Public security organ investigates the suspected illegal crimes of rabies vaccine produced by long-lived organisms

July 23rd:Long-lived creatures received notice of investigation by the Securities and Futures Commission

July 23rd:"Problem Vaccine" Event Continues Fermentation Contax Bio is caught in a paradox

July 23rd:Changchun Changsheng sales agent was involved in 12 bribery cases: the four provinces involved in Henan, Guangdong and Guangdong, who are collecting money

July 23rd:Changchun Changsheng was involved in more than a dozen bribery cases: each 72 yuan rabies vaccine rebate 20 yuan

July 23rd:Is the fund manager of the first performance this year a domestic vaccine platform a rational or an interest?

July 22nd:Li Keqiang gave instructions on the vaccine incident: he must give a clear explanation to the people of the country.

July 22nd:The State Food and Drug Administration has filed an investigation! Longevity: I feel very guilty and embarrassed

July 22nd:The five major official media criticized the longevity problem vaccine: Can you apologize? Have a check!

July 22nd:Changsheng Biological Sales Director: Shandong Province has introduced a plan for the replacement of white and white

July 21st:The king of vaccines is the road to fraud: the boss of the longevity creature has grown to 5.5 billion in ten years.

July 20th:Longevity: It is expected that the rabies vaccine incident will reduce the annual income of 720 million in 2018

July 19th:Changsheng Biology: Changchun Changsheng, a wholly-owned subsidiary, received an administrative penalty decision and was fined 3.44 million yuan.

July 16th:Long-lived biological rabies vaccine production record fraud, the vaccine has not yet flowed to the market

July 15th:The State Food and Drug Administration retracted the GMP certificate for longevity biological drugs and ordered the company to stop rabies vaccine production.

  [Illustrated event]

  Graphic Gao Junfang, Du Weimin, Han Gangjun three "vaccine giants" family history